Major advance in designer drug development

October 14, 2016

In a world-first, researchers from The University of Queensland and University of Washington (UW) have produced tailor-made peptides – an advance expected to help improve drug design and environmentally-friendly pesticides.

Peptides – naturally occurring chains of – are highly desired in drug development but can be unstable.

The team from the UQ's Institute for Molecular Bioscience (IMB) and UW's Institute for Protein Design has designed ultra-stable peptide scaffolds that can be used in a range of biotechnological applications.

Professor David Craik said these could have excellent pharmaceutical properties, combining the stability and tissue penetration of small-molecule drugs with the specificity of much larger protein therapeutics.

"Peptides are generally more specific than traditional 'small molecule' drugs, which means they have fewer side effects and are more potent," Professor Craik said.

"Until now, researchers have had to rely on natural peptides to provide drug scaffolds, which meant their work was limited by the availability of natural peptides with a particular shape and chemical characteristics.

"Along with Professor David Baker's team from UW, we have developed a new method where we can tailor the peptides into virtually any shape, and encourage them to adopt useful chemical characteristics and resist biological degradation.

"This is a major step forward that opens new avenues in peptide research and is expected to have a significant global impact."

The research was published in Nature.

Explore further: Plant kingdom provides two new candidates for the war on antibiotic resistance

More information: Gaurav Bhardwaj et al. Accurate de novo design of hyperstable constrained peptides, Nature (2016). DOI: 10.1038/nature19791

Related Stories

Cyclic opioid peptides

July 13, 2016

Peptide based drug candidates are being discovered at an increasingly rapid pace as therapeutics for many diseases and pain management. . For decades the opioid receptors have been an attractive therapeutic target for pain ...

A new synthetic amino acid for an emerging class of drugs

August 31, 2014

Swiss scientists have developed a new amino acid that can be used to modify the 3-D structure of therapeutic peptides. Insertion of the amino acid into bioactive peptides enhanced their binding affinity up to 40-fold. Peptides ...

New approach gives peptides a longer life

November 2, 2015

Researchers at University of the Pacific have developed a biochemical trick that can significantly extend the lifespan of peptides, smaller cousins of proteins. The finding opens up new possibilities for creating peptides ...

Promising compounds against a cancer target

February 3, 2016

Advances in new treatments for diseases, including cancer, come about from innovative research with therapeutic potential. This was the starting point for the Peptides and Proteins Lab at the Institute for Research in Biomedicine ...

Recommended for you

New X-ray spectroscopy explores hydrogen-generating catalyst

November 22, 2017

Using a newly developed technique, researchers from Japan, Germany and the U.S. have identified a key step in production of hydrogen gas by a bacterial enzyme. Understanding these reactions could be important in developing ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.